Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stool sample screening could revolutionize digestive cancer detection

NCT ID NCT07600125

Diagnosis Sponsor: Xijing Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study aims to see if testing stool samples for multiple markers can accurately screen for stomach and colorectal cancers. About 5,000 adults scheduled for endoscopy will provide a stool sample before the procedure and be followed for two years. The goal is to develop a non-invasive screening tool that could catch these cancers earlier.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will enroll individuals aged 18 and older who are scheduled to undergo gastrointestinal endoscopy and are willing to participate in the screening.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Participants must be at least 18 years of age at the time of enrollment; 2. Participants must be scheduled to undergo gastroscopy and colonoscopy; 3. Participants must agree to undergo a two-year follow-up as outlined in the protocol; 4. Participants must be willing to participate and sign an informed consent form. Exclusion Criteria: 1. Have undergone gastrointestinal endoscopy screening within the past year; 2. History of any type of gastrointestinal malignancy; 3. Concurrent severe medical conditions that reduce the benefits of screening, such as severe pulmonary disease, kidney disease, liver disease, cardiovascular and cerebrovascular diseases, and hematological disorders; 4. Other situations where a physician determines that endoscopic screening poses excessive risk (e.g., hemodynamic instability) or offers no benefit (e.g., short life expectancy); 5. Pregnant or breastfeeding women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastric cancer, colorectal cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cao County People's Hospital

    RECRUITING

    Heze, China

  • Central Theater Command General Hospital

    RECRUITING

    Wuhan, China

  • Gaoyao District People's Hospital, Zhaoqing City, Guangdong Province

    RECRUITING

    Zhaoqing, China

  • Hongxing Hospital of the 13th Division, Xinjiang Production and Construction Corps

    RECRUITING

    Hami, China

  • Huoqiu County People's Hospital

    RECRUITING

    Liu‘an, China

  • PetroChina Central Hospital, Hebei

    RECRUITING

    Langfang, China

  • Qingdao Municipal Hospital

    RECRUITING

    Qingdao, China

  • The 960th Hospital of the Joint Support Force of the People's Liberation Army of China

    RECRUITING

    Jinan, China

  • The First Affiliated Hospital of Air Force Military Medical University

    RECRUITING

    Xi'an, Shaanxi, 710032, China

  • The First Affiliated Hospital of Dalian Medical University

    RECRUITING

    Dalian, China

  • Wuwei Cancer Hospital of Gansu Province

    RECRUITING

    Wuwei, China

  • Wuxi People's Hospital

    RECRUITING

    Wuxi, China

  • Zhaoqing First People's Hospital, Guangdong Province

    RECRUITING

    Zhaoqing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.